Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Dermatology OTC Drug Market Growth (Status and Outlook) 2022-2028

  • LP 4890871
  • 111 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Dermatology OTC Drug will have significant change from previous year. According to our (LP Information) latest study, the global Dermatology OTC Drug market size is USD million in 2022 from USD 12500 million in 2021, with a change of % between 2021 and 2022. The global Dermatology OTC Drug market size will reach USD 15750 million in 2028, growing at a CAGR of 3.4% over the analysis period.

The United States Dermatology OTC Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermatology OTC Drug market, reaching US$ million by the year 2028. As for the Europe Dermatology OTC Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dermatology OTC Drug players cover Bayer, GSK, Teva, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology OTC Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Antifungals Medication

Skin Disinfection Medication

Skin Irritation Medication

Wounds and Herpes Simplex Medication

Anti-Psoriasis Medication

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Drug Store

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bayer

GSK

Teva

Johnson & Johnson

Novartis

Mylan

Sun Pharmaceutical

Aurobindo

Galderma

CR SANJIU

Dr. Reddy's

Lupin

Bausch Health

Cipla

Livzon

Almirall

Lingrui

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dermatology OTC Drug Market Size 2017-2028

2.1.2 Dermatology OTC Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Dermatology OTC Drug Segment by Type

2.2.1 Antifungals Medication

2.2.2 Skin Disinfection Medication

2.2.3 Skin Irritation Medication

2.2.4 Wounds and Herpes Simplex Medication

2.2.5 Anti-Psoriasis Medication

2.2.6 Other

2.3 Dermatology OTC Drug Market Size by Type

2.3.1 Dermatology OTC Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

2.4 Dermatology OTC Drug Segment by Application

2.4.1 Hospital

2.4.2 Drug Store

2.4.3 Other

2.5 Dermatology OTC Drug Market Size by Application

2.5.1 Dermatology OTC Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

3 Dermatology OTC Drug Market Size by Player

3.1 Dermatology OTC Drug Market Size Market Share by Players

3.1.1 Global Dermatology OTC Drug Revenue by Players (2020-2022)

3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2020-2022)

3.2 Global Dermatology OTC Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Dermatology OTC Drug by Regions

4.1 Dermatology OTC Drug Market Size by Regions (2017-2022)

4.2 Americas Dermatology OTC Drug Market Size Growth (2017-2022)

4.3 APAC Dermatology OTC Drug Market Size Growth (2017-2022)

4.4 Europe Dermatology OTC Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Dermatology OTC Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Dermatology OTC Drug Market Size by Country (2017-2022)

5.2 Americas Dermatology OTC Drug Market Size by Type (2017-2022)

5.3 Americas Dermatology OTC Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dermatology OTC Drug Market Size by Region (2017-2022)

6.2 APAC Dermatology OTC Drug Market Size by Type (2017-2022)

6.3 APAC Dermatology OTC Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Dermatology OTC Drug by Country (2017-2022)

7.2 Europe Dermatology OTC Drug Market Size by Type (2017-2022)

7.3 Europe Dermatology OTC Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dermatology OTC Drug by Region (2017-2022)

8.2 Middle East & Africa Dermatology OTC Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Dermatology OTC Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Dermatology OTC Drug Market Forecast

10.1 Global Dermatology OTC Drug Forecast by Regions (2023-2028)

10.1.1 Global Dermatology OTC Drug Forecast by Regions (2023-2028)

10.1.2 Americas Dermatology OTC Drug Forecast

10.1.3 APAC Dermatology OTC Drug Forecast

10.1.4 Europe Dermatology OTC Drug Forecast

10.1.5 Middle East & Africa Dermatology OTC Drug Forecast

10.2 Americas Dermatology OTC Drug Forecast by Country (2023-2028)

10.2.1 United States Dermatology OTC Drug Market Forecast

10.2.2 Canada Dermatology OTC Drug Market Forecast

10.2.3 Mexico Dermatology OTC Drug Market Forecast

10.2.4 Brazil Dermatology OTC Drug Market Forecast

10.3 APAC Dermatology OTC Drug Forecast by Region (2023-2028)

10.3.1 China Dermatology OTC Drug Market Forecast

10.3.2 Japan Dermatology OTC Drug Market Forecast

10.3.3 Korea Dermatology OTC Drug Market Forecast

10.3.4 Southeast Asia Dermatology OTC Drug Market Forecast

10.3.5 India Dermatology OTC Drug Market Forecast

10.3.6 Australia Dermatology OTC Drug Market Forecast

10.4 Europe Dermatology OTC Drug Forecast by Country (2023-2028)

10.4.1 Germany Dermatology OTC Drug Market Forecast

10.4.2 France Dermatology OTC Drug Market Forecast

10.4.3 UK Dermatology OTC Drug Market Forecast

10.4.4 Italy Dermatology OTC Drug Market Forecast

10.4.5 Russia Dermatology OTC Drug Market Forecast

10.5 Middle East & Africa Dermatology OTC Drug Forecast by Region (2023-2028)

10.5.1 Egypt Dermatology OTC Drug Market Forecast

10.5.2 South Africa Dermatology OTC Drug Market Forecast

10.5.3 Israel Dermatology OTC Drug Market Forecast

10.5.4 Turkey Dermatology OTC Drug Market Forecast

10.5.5 GCC Countries Dermatology OTC Drug Market Forecast

10.6 Global Dermatology OTC Drug Forecast by Type (2023-2028)

10.7 Global Dermatology OTC Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Dermatology OTC Drug Product Offered

11.1.3 Bayer Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bayer Main Business Overview

11.1.5 Bayer Latest Developments

11.2 GSK

11.2.1 GSK Company Information

11.2.2 GSK Dermatology OTC Drug Product Offered

11.2.3 GSK Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GSK Main Business Overview

11.2.5 GSK Latest Developments

11.3 Teva

11.3.1 Teva Company Information

11.3.2 Teva Dermatology OTC Drug Product Offered

11.3.3 Teva Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Teva Main Business Overview

11.3.5 Teva Latest Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Dermatology OTC Drug Product Offered

11.4.3 Johnson & Johnson Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Johnson & Johnson Main Business Overview

11.4.5 Johnson & Johnson Latest Developments

11.5 Novartis

11.5.1 Novartis Company Information

11.5.2 Novartis Dermatology OTC Drug Product Offered

11.5.3 Novartis Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Novartis Main Business Overview

11.5.5 Novartis Latest Developments

11.6 Mylan

11.6.1 Mylan Company Information

11.6.2 Mylan Dermatology OTC Drug Product Offered

11.6.3 Mylan Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Mylan Main Business Overview

11.6.5 Mylan Latest Developments

11.7 Sun Pharmaceutical

11.7.1 Sun Pharmaceutical Company Information

11.7.2 Sun Pharmaceutical Dermatology OTC Drug Product Offered

11.7.3 Sun Pharmaceutical Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Sun Pharmaceutical Main Business Overview

11.7.5 Sun Pharmaceutical Latest Developments

11.8 Aurobindo

11.8.1 Aurobindo Company Information

11.8.2 Aurobindo Dermatology OTC Drug Product Offered

11.8.3 Aurobindo Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Aurobindo Main Business Overview

11.8.5 Aurobindo Latest Developments

11.9 Galderma

11.9.1 Galderma Company Information

11.9.2 Galderma Dermatology OTC Drug Product Offered

11.9.3 Galderma Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Galderma Main Business Overview

11.9.5 Galderma Latest Developments

11.10 CR SANJIU

11.10.1 CR SANJIU Company Information

11.10.2 CR SANJIU Dermatology OTC Drug Product Offered

11.10.3 CR SANJIU Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 CR SANJIU Main Business Overview

11.10.5 CR SANJIU Latest Developments

11.11 Dr. Reddy's

11.11.1 Dr. Reddy's Company Information

11.11.2 Dr. Reddy's Dermatology OTC Drug Product Offered

11.11.3 Dr. Reddy's Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Dr. Reddy's Main Business Overview

11.11.5 Dr. Reddy's Latest Developments

11.12 Lupin

11.12.1 Lupin Company Information

11.12.2 Lupin Dermatology OTC Drug Product Offered

11.12.3 Lupin Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Lupin Main Business Overview

11.12.5 Lupin Latest Developments

11.13 Bausch Health

11.13.1 Bausch Health Company Information

11.13.2 Bausch Health Dermatology OTC Drug Product Offered

11.13.3 Bausch Health Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Bausch Health Main Business Overview

11.13.5 Bausch Health Latest Developments

11.14 Cipla

11.14.1 Cipla Company Information

11.14.2 Cipla Dermatology OTC Drug Product Offered

11.14.3 Cipla Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Cipla Main Business Overview

11.14.5 Cipla Latest Developments

11.15 Livzon

11.15.1 Livzon Company Information

11.15.2 Livzon Dermatology OTC Drug Product Offered

11.15.3 Livzon Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Livzon Main Business Overview

11.15.5 Livzon Latest Developments

11.16 Almirall

11.16.1 Almirall Company Information

11.16.2 Almirall Dermatology OTC Drug Product Offered

11.16.3 Almirall Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Almirall Main Business Overview

11.16.5 Almirall Latest Developments

11.17 Lingrui

11.17.1 Lingrui Company Information

11.17.2 Lingrui Dermatology OTC Drug Product Offered

11.17.3 Lingrui Dermatology OTC Drug Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Lingrui Main Business Overview

11.17.5 Lingrui Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Dermatology OTC Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antifungals Medication

Table 3. Major Players of Skin Disinfection Medication

Table 4. Major Players of Skin Irritation Medication

Table 5. Major Players of Wounds and Herpes Simplex Medication

Table 6. Major Players of Anti-Psoriasis Medication

Table 7. Major Players of Other

Table 8. Dermatology OTC Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Dermatology OTC Drug Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

Table 11. Dermatology OTC Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Dermatology OTC Drug Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

Table 14. Global Dermatology OTC Drug Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Dermatology OTC Drug Revenue Market Share by Player (2020-2022)

Table 16. Dermatology OTC Drug Key Players Head office and Products Offered

Table 17. Dermatology OTC Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Dermatology OTC Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Dermatology OTC Drug Market Size Market Share by Regions (2017-2022)

Table 22. Americas Dermatology OTC Drug Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Dermatology OTC Drug Market Size Market Share by Country (2017-2022)

Table 24. Americas Dermatology OTC Drug Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

Table 26. Americas Dermatology OTC Drug Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

Table 28. APAC Dermatology OTC Drug Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Dermatology OTC Drug Market Size Market Share by Region (2017-2022)

Table 30. APAC Dermatology OTC Drug Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

Table 32. APAC Dermatology OTC Drug Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

Table 34. Europe Dermatology OTC Drug Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Dermatology OTC Drug Market Size Market Share by Country (2017-2022)

Table 36. Europe Dermatology OTC Drug Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

Table 38. Europe Dermatology OTC Drug Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Dermatology OTC Drug Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Dermatology OTC Drug Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Dermatology OTC Drug Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Dermatology OTC Drug

Table 47. Key Market Challenges & Risks of Dermatology OTC Drug

Table 48. Key Industry Trends of Dermatology OTC Drug

Table 49. Global Dermatology OTC Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Dermatology OTC Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Dermatology OTC Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Dermatology OTC Drug Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Dermatology OTC Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Dermatology OTC Drug Market Size Market Share Forecast by Application (2023-2028)

Table 55. Bayer Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 56. Bayer Dermatology OTC Drug Product Offered

Table 57. Bayer Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Bayer Main Business

Table 59. Bayer Latest Developments

Table 60. GSK Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 61. GSK Dermatology OTC Drug Product Offered

Table 62. GSK Main Business

Table 63. GSK Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. GSK Latest Developments

Table 65. Teva Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 66. Teva Dermatology OTC Drug Product Offered

Table 67. Teva Main Business

Table 68. Teva Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Teva Latest Developments

Table 70. Johnson & Johnson Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 71. Johnson & Johnson Dermatology OTC Drug Product Offered

Table 72. Johnson & Johnson Main Business

Table 73. Johnson & Johnson Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Johnson & Johnson Latest Developments

Table 75. Novartis Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 76. Novartis Dermatology OTC Drug Product Offered

Table 77. Novartis Main Business

Table 78. Novartis Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Novartis Latest Developments

Table 80. Mylan Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 81. Mylan Dermatology OTC Drug Product Offered

Table 82. Mylan Main Business

Table 83. Mylan Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Mylan Latest Developments

Table 85. Sun Pharmaceutical Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 86. Sun Pharmaceutical Dermatology OTC Drug Product Offered

Table 87. Sun Pharmaceutical Main Business

Table 88. Sun Pharmaceutical Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Sun Pharmaceutical Latest Developments

Table 90. Aurobindo Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 91. Aurobindo Dermatology OTC Drug Product Offered

Table 92. Aurobindo Main Business

Table 93. Aurobindo Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Aurobindo Latest Developments

Table 95. Galderma Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 96. Galderma Dermatology OTC Drug Product Offered

Table 97. Galderma Main Business

Table 98. Galderma Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Galderma Latest Developments

Table 100. CR SANJIU Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 101. CR SANJIU Dermatology OTC Drug Product Offered

Table 102. CR SANJIU Main Business

Table 103. CR SANJIU Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. CR SANJIU Latest Developments

Table 105. Dr. Reddy's Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 106. Dr. Reddy's Dermatology OTC Drug Product Offered

Table 107. Dr. Reddy's Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Dr. Reddy's Main Business

Table 109. Dr. Reddy's Latest Developments

Table 110. Lupin Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 111. Lupin Dermatology OTC Drug Product Offered

Table 112. Lupin Main Business

Table 113. Lupin Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Lupin Latest Developments

Table 115. Bausch Health Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 116. Bausch Health Dermatology OTC Drug Product Offered

Table 117. Bausch Health Main Business

Table 118. Bausch Health Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Bausch Health Latest Developments

Table 120. Cipla Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 121. Cipla Dermatology OTC Drug Product Offered

Table 122. Cipla Main Business

Table 123. Cipla Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Cipla Latest Developments

Table 125. Livzon Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 126. Livzon Dermatology OTC Drug Product Offered

Table 127. Livzon Main Business

Table 128. Livzon Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 129. Livzon Latest Developments

Table 130. Almirall Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 131. Almirall Dermatology OTC Drug Product Offered

Table 132. Almirall Main Business

Table 133. Almirall Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 134. Almirall Latest Developments

Table 135. Lingrui Details, Company Type, Dermatology OTC Drug Area Served and Its Competitors

Table 136. Lingrui Dermatology OTC Drug Product Offered

Table 137. Lingrui Main Business

Table 138. Lingrui Dermatology OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 139. Lingrui Latest Developments

List of Figures

Figure 1. Dermatology OTC Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Dermatology OTC Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Dermatology OTC Drug Market Size Market Share by Type in 2021

Figure 7. Dermatology OTC Drug in Hospital

Figure 8. Global Dermatology OTC Drug Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Dermatology OTC Drug in Drug Store

Figure 10. Global Dermatology OTC Drug Market: Drug Store (2017-2022) & ($ Millions)

Figure 11. Dermatology OTC Drug in Other

Figure 12. Global Dermatology OTC Drug Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Dermatology OTC Drug Market Size Market Share by Application in 2021

Figure 14. Global Dermatology OTC Drug Revenue Market Share by Player in 2021

Figure 15. Global Dermatology OTC Drug Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Dermatology OTC Drug Market Size 2017-2022 ($ Millions)

Figure 17. APAC Dermatology OTC Drug Market Size 2017-2022 ($ Millions)

Figure 18. Europe Dermatology OTC Drug Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Dermatology OTC Drug Market Size 2017-2022 ($ Millions)

Figure 20. Americas Dermatology OTC Drug Value Market Share by Country in 2021

Figure 21. Americas Dermatology OTC Drug Consumption Market Share by Type in 2021

Figure 22. Americas Dermatology OTC Drug Market Size Market Share by Application in 2021

Figure 23. United States Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Dermatology OTC Drug Market Size Market Share by Region in 2021

Figure 28. APAC Dermatology OTC Drug Market Size Market Share by Application in 2021

Figure 29. China Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Dermatology OTC Drug Market Size Market Share by Country in 2021

Figure 36. Europe Dermatology OTC Drug Market Size Market Share by Type in 2021

Figure 37. Europe Dermatology OTC Drug Market Size Market Share by Application in 2021

Figure 38. Germany Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Dermatology OTC Drug Market Size Market Share by Application in 2021

Figure 46. Egypt Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Dermatology OTC Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 52. APAC Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 53. Europe Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 55. United States Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 56. Canada Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 59. China Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 60. Japan Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 61. Korea Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 63. India Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 64. Australia Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 65. Germany Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 66. France Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 67. UK Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 68. Italy Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 69. Russia Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 70. Spain Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 73. Israel Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Dermatology OTC Drug Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450